Measuring the HIV/AIDS epidemic: approaches and challenges.

In this article, the author reviews current approaches and methods for measuring the scope of the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic and their strengths and weaknesses. In recent years, various public health agencies have revised statistical estimates of the scope of the HIV/AIDS pandemic. The author considers the reasons underlying these revisions. New sources of data for estimating HIV prevalence have become available, such as nationally representative probability-based surveys. New technologies such as biomarkers that indicate when persons became infected are now used to determine HIV incidence rates. The author summarizes the main sources of errors and problems with these and other approaches and discusses opportunities for improving their reliability. Changing methods and data sources present new challenges, because incidence and prevalence estimates produced at different points in time are not directly comparable with each other, which complicates assessment of time trends. The methodological changes help explain the changes in global statistics. As methods and data sources continue to improve, the development of statistical tools for better assessing the extent to which changes in HIV/AIDS statistics can be attributed to changes in methodology versus real changes in the underlying epidemic is an important challenge.

[1]  J Stover,et al.  Projecting the demographic consequences of adult HIV prevalence trends: the Spectrum Projection Package , 2004, Sexually Transmitted Infections.

[2]  R. Brookmeyer Accounting for Follow‐up Bias in Estimation of Human Immunodeficiency Virus Incidence Rates , 1997 .

[3]  O. Laeyendecker,et al.  The Effect of Viral Suppression on Cross-Sectional Incidence Testing in the Johns Hopkins Hospital Emergency Department , 2008, Journal of acquired immune deficiency syndromes.

[4]  B. Branson,et al.  Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. , 2006, AIDS research and human retroviruses.

[5]  A. Gillies,et al.  Book review: The AIDS Pandemic: the collision of epidemiology with political correctness , 2007 .

[6]  D. Payne The AIDS Pandemic - The Collision of Epidemiology with Political Correctness James Chin The AIDS Pandemic - The Collision of Epidemiology with Political Correctness Radcliffe 230 £27.50 1 84619 118 1 1846191181 [Formula: see text]. , 2007, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[7]  R. Byers,et al.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. , 2002, AIDS research and human retroviruses.

[8]  T. Farley,et al.  Estimating HIV Incidence and Detection Rates From Surveillance Data , 2004, Epidemiology.

[9]  R. Brookmeyer,et al.  Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results , 2008, Statistics in medicine.

[10]  Ekkehard Kopp,et al.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay , 2008, AIDS.

[11]  R. Steketee,et al.  HIV in the United States at the turn of the century: an epidemic in transition. , 2001, American journal of public health.

[12]  D. Kruszon-Moran,et al.  Prevalence of HIV in the US Household Population: The National Health and Nutrition Examination Surveys, 1988 to 2002 , 2006, Journal of acquired immune deficiency syndromes.

[13]  H. Hull,et al.  Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. , 1988, JAMA.

[14]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[15]  R Bellocco,et al.  Joint analysis of HIV and AIDS surveillance data in back-calculation. , 2000, Statistics in medicine.

[16]  Shandir Ramlagan,et al.  South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey, 2005 , 2008 .

[17]  J Ties Boerma,et al.  Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard , 2003, The Lancet.

[18]  S. Karim,et al.  Estimating HIV incidence rates from age prevalence data in epidemic situations , 2001, Statistics in medicine.

[19]  R. Brookmeyer Response to correspondence on 'should biomarker estimates of HIV incidence be adjusted?' , 2009 .

[20]  Jim Todd,et al.  Estimating Incidence from Prevalence in Generalised HIV Epidemics: Methods and Validation , 2008, PLoS medicine.

[21]  UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. , 2006, Releve epidemiologique hebdomadaire.

[22]  D. Kruszon-Moran,et al.  Seroprevalence of HIV in the US Household Population Aged 18-49 Years: The National Health and Nutrition Examination Surveys, 1999-2006 , 2010, Journal of acquired immune deficiency syndromes.

[23]  Coolfont report: a PHS plan for prevention and control of AIDS and AIDS virus. , 1986, Public health reports.

[24]  Edward H. Kaplan,et al.  Snapshot Estimators of Recent HIV Incidence Rates , 1999, Oper. Res..

[25]  Michael X. Repka,et al.  Response to Correspondence , 2007 .

[26]  N. Grassly,et al.  The workbook approach to making estimates and projecting future scenarios of HIV/AIDS in countries with low level and concentrated epidemics , 2004, Sexually Transmitted Infections.

[27]  N. Walker,et al.  Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections , 2008, Sexually Transmitted Infections.

[28]  V. Mishra,et al.  Comparison of HIV prevalence estimates from antenatal care surveillance and population-based surveys in sub-Saharan Africa , 2008, Sexually Transmitted Infections.

[29]  R. Remis,et al.  Testing bias in calculating HIV incidence from the Serologic Testing Algorithm for Recent HIV Seroconversion , 2009, AIDS.

[30]  M. Dybul,et al.  AIDS: lessons learnt and myths dispelled , 2009, The Lancet.

[31]  A. Kamali,et al.  Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa , 2007, AIDS.

[32]  L Meyer,et al.  Principles and uses of HIV incidence estimation from recent infection testing--a review. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  G A Satten,et al.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.

[34]  A. Raftery,et al.  Bayesian melding for estimating uncertainty in national HIV prevalence estimates , 2008, Sexually Transmitted Infections.

[35]  M. Marston,et al.  Non-response bias in estimates of HIV prevalence due to the mobility of absentees in national population-based surveys: a study of nine national surveys , 2008, Sexually Transmitted Infections.

[36]  P. Ghys,et al.  Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics , 2006, Sexually Transmitted Infections.

[37]  S. Cole,et al.  Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data. , 2006, American journal of epidemiology.

[38]  R Brookmeyer,et al.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.

[39]  Mitchell H. Gail,et al.  AIDS Epidemiology: A Quantitative Approach , 1994 .

[40]  J Stover,et al.  The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics , 2004, Sexually Transmitted Infections.

[41]  V. Mishra,et al.  Evaluating HIV estimates from national population-based surveys for bias resulting from non-response , 2008 .

[42]  Lisa M. Lee,et al.  Estimation of HIV incidence in the United States. , 2008, JAMA.

[43]  Thomas Rehle,et al.  South African national HIV prevalence, incidence, behaviour and communication survey, 2008: a turning tide among teenagers? , 2009 .

[44]  E. Gouws,et al.  Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data , 2008, Sexually Transmitted Infections.

[45]  W. Hladik,et al.  HIV Prevalence in Voluntary Counseling and Testing Centers Compared With National HIV Serosurvey Data in Uganda , 2008, Journal of acquired immune deficiency syndromes.

[46]  V. Mishra,et al.  Evaluation of bias in HIV seroprevalence estimates from national household surveys , 2008, Sexually Transmitted Infections.

[47]  Geoff P Garnett,et al.  Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? , 2004, The Lancet.

[48]  A. Welte,et al.  Relating recent infection prevalence to incidence with a sub-population of assay non-progressors , 2010, Journal of mathematical biology.

[49]  B. Barrère,et al.  HIV prevalence estimates from the Demographic and Health Surveys. Updated June 2010. , 2008 .

[50]  J. Eaton,et al.  Refusal bias in HIV prevalence estimates from nationally representative seroprevalence surveys , 2009, AIDS.

[51]  J. Parry,et al.  Assays for the detection of recent infections with human immunodeficiency virus type 1. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[52]  E. Piwoz,et al.  An education and counseling program for preventing breast-feeding-associated HIV transmission in Zimbabwe: design and impact on maternal knowledge and behavior. , 2005, The Journal of nutrition.

[53]  N E Day,et al.  A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: application to AIDS prediction in England and Wales. , 1997, Statistics in medicine.

[54]  E. Piwoz,et al.  Women's voices, women's choices: the challenge of nutrition and HIV/AIDS. , 2005, The Journal of nutrition.

[55]  R. Mikolajczyk,et al.  Time Trends and Regional Differences in the Prevalence of HIV Infection Among Women Attending Antenatal Clinics in 2 Provinces in Cameroon , 2009, Journal of acquired immune deficiency syndromes.

[56]  N G Becker,et al.  Estimating HIV incidence using dates of both HIV and AIDS diagnoses. , 2000, Statistics in medicine.

[57]  T. Bärnighausen,et al.  A Simplified Formula for Inferring HIV Incidence from Cross-Sectional Surveys Using a Test for Recent Infection. , 2009, AIDS research and human retroviruses.